BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15934943)

  • 1. HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells.
    Hayashi K; Pu H; Tian J; Andras IE; Lee YW; Hennig B; Toborek M
    J Neurochem; 2005 Jun; 93(5):1231-41. PubMed ID: 15934943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.
    Hayashi K; Pu H; Andras IE; Eum SY; Yamauchi A; Hennig B; Toborek M
    J Cereb Blood Flow Metab; 2006 Aug; 26(8):1052-65. PubMed ID: 16395283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells.
    András IE; Pu H; Tian J; Deli MA; Nath A; Hennig B; Toborek M
    J Cereb Blood Flow Metab; 2005 Sep; 25(9):1159-70. PubMed ID: 15815581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium.
    Toborek M; Lee YW; Pu H; Malecki A; Flora G; Garrido R; Hennig B; Bauer HC; Nath A
    J Neurochem; 2003 Jan; 84(1):169-79. PubMed ID: 12485413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats: evidence for the involvement of nuclear factor-kappaB, a nitrosative stress-sensitive transcription factor, in the regulation.
    Maeng HJ; Kim MH; Jin HE; Shin SM; Tsuruo T; Kim SG; Kim DD; Shim CK; Chung SJ
    Drug Metab Dispos; 2007 Nov; 35(11):1996-2005. PubMed ID: 17664251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
    Yousif S; Chaves C; Potin S; Margaill I; Scherrmann JM; Declèves X
    J Neurochem; 2012 Nov; 123(4):491-503. PubMed ID: 22845665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism.
    Zhu HJ; Liu GQ
    Life Sci; 2004 Jul; 75(11):1313-22. PubMed ID: 15234189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.
    Chen Y; Agarwal S; Shaik NM; Chen C; Yang Z; Elmquist WF
    J Pharmacol Exp Ther; 2009 Sep; 330(3):956-63. PubMed ID: 19491323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
    András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
    J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of an In-Cell Western for Quantifying P-Glycoprotein Expression in Human Brain Microvascular Endothelial (hCMEC/D3) Cells.
    McInerney MP; Pan Y; Short JL; Nicolazzo JA
    J Pharm Sci; 2017 Sep; 106(9):2614-2624. PubMed ID: 28065764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.
    Shaik N; Giri N; Pan G; Elmquist WF
    Drug Metab Dispos; 2007 Nov; 35(11):2076-85. PubMed ID: 17709369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.
    Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE
    Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells.
    Zhong Y; Hennig B; Toborek M
    J Cereb Blood Flow Metab; 2010 Mar; 30(3):522-33. PubMed ID: 19794400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of melatonin receptor (MT1/2) promotes P-gp transporter in methamphetamine-induced toxicity on primary rat brain microvascular endothelial cells.
    Jumnongprakhon P; Sivasinprasasn S; Govitrapong P; Tocharus C; Tocharus J
    Toxicol In Vitro; 2017 Jun; 41():42-48. PubMed ID: 28223141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes.
    Liu H; Liu X; Jia L; Liu Y; Yang H; Wang G; Xie L
    Biochem Pharmacol; 2008 Apr; 75(8):1649-58. PubMed ID: 18299117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells.
    Lee YW; Eum SY; Nath A; Toborek M
    Cardiovasc Res; 2004 Jul; 63(1):139-48. PubMed ID: 15194470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.
    Miller DW; Hinton M; Chen F
    Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.